A
Astute Medical
By incoporating useful clinical tools, we help healthcare professionals provide rapid, accurate and life-saving responses
About Astute Medical
Astute Medical specializes in improving patient outcomes by identifying and validating biomarkers through advanced technology. The company operates in the healthcare diagnostics market, primarily serving hospitals and clinical laboratories. Astute Medical's core product is a Test System that utilizes immunoassay technology to detect changes in biomarker measurements, which correlate with the risk of Acute Kidney Injury (AKI). The test is performed on a small cartridge that employs proprietary microfluidic engineering for sample processing, and the results are read by a bench-top Meter. The business model is based on the sale of these diagnostic tests and the associated equipment, as well as licensing its intellectual property. Revenue is generated through direct sales to healthcare providers and through partnerships with other medical technology companies. Astute Medical holds a robust portfolio of intellectual property, including over 30 published international patent applications, which protect its innovative processes and technologies in major markets such as the United States, Canada, Japan, China, India, and the European Union.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Employees
- 39
- Open positions
- None listed
- Dealroom signal
- 58.1/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Intellectual Property, Risk Management, Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
- Client focus
- B2C
- Investment activity
- 1 company, latest Mar 2022
- Capital deployed
- —
- Preferred round
- ACQUISITION
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | Apr 2018 | $0 | — | BioMérieux | ↗ |
| LATE VCOther financing | Dec 2016 | $43M | $172M | Bio-Techne | — |
Growth signals
Latest recorded traffic for Astute Medical is 180 monthly website visits, down 14.3% over the last three months. Astute Medical's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Astute Medical in the San Diego ecosystem
The Astute Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
- DVDeNovo Ventures
Delphi Ventures
Domain Associates
Johnson & Johnson
Series B and later5 investors entered at this stage
MPM BioImpact
Johnson & Johnson Development Corporation
Kaiser Permanente Ventures
Shanghai Fosun Pharmaceutical
Bio-Techne
Other known investors2 additional known investors
BioMérieux
University of Pittsburgh
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Astute Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Astute Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









